Farther Finance Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.61K Sell
589
-2,274
-79% -$42.7K ﹤0.01% 4642
2026
Q2
$43.3K Sell
2,863
-258
-8% -$4.5K ﹤0.01% 3359
2026
Q1
$58.7K Sell
3,121
-479
-13% -$10.4K ﹤0.01% 2881
2025
Q4
$79.1K Buy
3,600
+965
+37% +$17.4K ﹤0.01% 2496
2025
Q3
$32K Sell
2,635
-2
-0.1% -$27 ﹤0.01% 2728
2025
Q2
$49.2K Sell
2,637
-1,479
-36% -$29.3K ﹤0.01% 2142
2025
Q1
$77.1K Buy
4,116
+350
+9% +$10.2K ﹤0.01% 1669
2024
Q4
$136K Buy
3,766
+1
+0% +$34 ﹤0.01% 1178
2024
Q3
$160K Sell
3,765
-476
-11% -$20.2K 0.01% 1091
2024
Q2
$167K Buy
4,241
+27
+0.6% +$1.13K 0.01% 918
2024
Q1
$143K Buy
4,214
+3,541
+526% +$94.9K 0.01% 818
2023
Q4
$19.9K Buy
673
+173
+35% +$3.59K ﹤0.01% 1335
2023
Q3
$10.4K Sell
500
-5
-1% -$137 ﹤0.01% 1279
2023
Q2
$12.4K Buy
505
+5
+1% +$161 ﹤0.01% 1134
2023
Q1
$20.3K Sell
500
-3
-0.6% -$124 0.01% 899
2022
Q4
$22.6K Buy
+503
New +$22.8K 0.01% 696

Other funds holding TNDM

Farther Finance Advisors's TNDM Position: Q3 2026 in Review

Farther Finance Advisors reduced its Tandem Diabetes Care (TNDM) stake by 79% in Q3 2026, selling an estimated $42.7K and leaving 589 shares worth $9.61K. The position accounts for ﹤0.01% of the portfolio, ranked #4642.

Farther Finance Advisors first reported a position in TNDM in Q4 2022 and has held it in 16 quarters since. The position peaked at $167K in Q2 2024. 9 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Farther Finance Advisors held 589 shares of Tandem Diabetes Care worth $9.61K as of Q3 2026.
  • Farther Finance Advisors sold 2,274 Tandem Diabetes Care shares in Q3 2026, an estimated $42.7K.
  • Tandem Diabetes Care made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4642 holding.
  • Farther Finance Advisors first reported a position in Tandem Diabetes Care in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Tandem Diabetes Care position peaked at $167K in Q2 2024.
  • 9 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.